3.0.0
1246
2025-12-05T09:12:12Z
2025-12-05T09:12:12Z
Senate
S
S
2023-04-20
118
https://www.congress.gov/bill/118th-congress/senate-bill/1246
- ssfi00
Finance Committee
Senate
Standing
  - Referred To
2023-04-20T18:38:57Z

- SMART Prices Act
118
1264
S
2023-04-25
Read twice and referred to the Committee on Finance.
  - Identical bill
CRS
- 2023-04-20
  - ssfi00
Finance Committee
Senate
Read twice and referred to the Committee on Finance.
IntroReferral
- 2023-04-20
Introduced in Senate
IntroReferral
10000
9
Library of Congress
- K000367
Sen. Klobuchar, Amy [D-MN]
Amy
Klobuchar
D
MN
N
- W000800
Sen. Welch, Peter [D-VT]
Peter
Welch
D
VT
2023-04-20
True
- G000555
Sen. Gillibrand, Kirsten E. [D-NY]
Kirsten
Gillibrand
D
NY
E.
2023-04-20
True
- H001046
Sen. Heinrich, Martin [D-NM]
Martin
Heinrich
D
NM
T.
2023-04-20
True
- M001176
Sen. Merkley, Jeff [D-OR]
Jeff
Merkley
D
OR
2023-04-20
True
- S000770
Sen. Stabenow, Debbie [D-MI]
Debbie
Stabenow
D
MI
2023-04-20
True
- R000122
Sen. Reed, Jack [D-RI]
John
Reed
D
RI
F.
2023-04-20
True
- W000802
Sen. Whitehouse, Sheldon [D-RI]
Sheldon
Whitehouse
D
RI
2023-04-20
True
- B001277
Sen. Blumenthal, Richard [D-CT]
Richard
Blumenthal
D
CT
2023-04-20
True
- C001113
Sen. Cortez Masto, Catherine [D-NV]
Catherine
Cortez Masto
D
NV
2023-04-20
True
- H001076
Sen. Hassan, Margaret Wood [D-NH]
Maggie
Hassan
D
NH
2023-04-20
True
- K000383
Sen. King, Angus S., Jr. [I-ME]
Angus
King
I
ME
S.
2023-04-20
True
- C000127
Sen. Cantwell, Maria [D-WA]
Maria
Cantwell
D
WA
2023-04-20
True
- S001181
Sen. Shaheen, Jeanne [D-NH]
Jeanne
Shaheen
D
NH
2023-04-20
True
- B001230
Sen. Baldwin, Tammy [D-WI]
Tammy
Baldwin
D
WI
2023-04-20
True
- D000563
Sen. Durbin, Richard J. [D-IL]
Richard
Durbin
D
IL
J.
2023-04-20
True
- B000944
Sen. Brown, Sherrod [D-OH]
Sherrod
Brown
D
OH
2023-04-20
True
- B001288
Sen. Booker, Cory A. [D-NJ]
Cory
Booker
D
NJ
2023-04-20
True
- S001203
Sen. Smith, Tina [D-MN]
Tina
Smith
D
MN
2023-04-20
True
- W000817
Sen. Warren, Elizabeth [D-MA]
Elizabeth
Warren
D
MA
A.
2023-04-20
True
- M001111
Sen. Murray, Patty [D-WA]
Patty
Murray
D
WA
2023-04-20
True
- C000141
Sen. Cardin, Benjamin L. [D-MD]
Ben
Cardin
D
MD
2023-04-20
True
- D000622
Sen. Duckworth, Tammy [D-IL]
Tammy
Duckworth
D
IL
2023-04-20
True
- M000133
Sen. Markey, Edward J. [D-MA]
Edward
Markey
D
MA
J.
2023-04-20
True
- B001267
Sen. Bennet, Michael F. [D-CO]
Michael
Bennet
D
CO
2023-05-02
False
- V000128
Sen. Van Hollen, Chris [D-MD]
Chris
Van Hollen
D
MD
2023-05-02
False
- F000479
Sen. Fetterman, John [D-PA]
John
Fetterman
D
PA
K.
2023-05-02
False
- S000033
Sen. Sanders, Bernard [I-VT]
Bernard
Sanders
I
VT
2023-05-03
False
- W000790
Sen. Warnock, Raphael G. [D-GA]
Raphael
Warnock
D
GA
2023-06-07
False
- M001169
Sen. Murphy, Christopher [D-CT]
Christopher
Murphy
D
CT
S.
2023-07-26
False
Health
Health
2023-04-27T17:15:58Z
00
2023-04-20
Introduced in Senate
2023-11-29T22:06:09Z
Strengthening Medicare And Reducing Taxpayer Prices Act or the SMART Prices Act
This bill modifies requirements of the Medicare Drug Price Negotiation Program and makes other changes with respect to the prices of prescription drugs under Medicare.
Current law requires the Centers for Medicare & Medicaid Services (CMS) to negotiate maximum prices for brand-name drugs that do not have other generic equivalents and that account for the greatest Medicare spending. The CMS must negotiate the prices of 10 drugs that are covered under the Medicare prescription drug benefit in 2026, 15 drugs that are covered under the Medicare prescription drug benefit in 2027, 15 drugs that are covered under the Medicare prescription drug benefit or under Medicare medical services in 2028, and 20 drugs that are covered under the Medicare prescription drug benefit or under Medicare medical services in 2029 and each year thereafter.
The bill requires the CMS to negotiate the prices of 20 drugs under the Medicare prescription drug benefit in 2026 and 40 drugs under the Medicare prescription drug benefit or under Medicare medical services in 2027 and each year thereafter. It also (1) shortens the required period of market approval from 7 years and 11 years for drugs and biologics, respectively, to 3 years; and (2) modifies the ceiling for the maximum fair price for short-, extended-, and long-monopoly drugs.
The bill also repeals provisions that prohibit the CMS from interfering in negotiations between drug manufacturers, pharmacies, and PDP sponsors (i.e., noninterference clause).

SMART Prices Act
- Display Title
45

SMART Prices Act
2024-07-24T15:22:39Z
- Short Title(s) as Introduced
101

SMART Prices Act
2024-05-24T13:40:50Z
Introduced in Senate
IS
- Short Title(s) as Introduced
101

Strengthening Medicare And Reducing Taxpayer Prices Act
2024-05-24T13:40:50Z
Introduced in Senate
IS
- Official Title as Introduced
6

A bill to amend title XVIII of the Social Security Act to strengthen the drug pricing reforms in the Inflation Reduction Act.
2023-04-26T01:58:50Z
Introduced in Senate
IS
- Introduced in Senate
2023-04-20T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118s1246is/xml/BILLS-118s1246is.xml
2023-04-20
Read twice and referred to the Committee on Finance.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.